SANJIVIN Sanjivani Paranteral Ltd Other Situations Announcement 2025 - Trading Approval Sanjivani Parenteral Ltd. has received approval from BSE Limited to trade 197,394 equity shares at a premium of Rs. 125.10, effective January 13, 2025..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sanjivani Paranteral Ltd